Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
1982 • 2,228 citations
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
1992 • 650 citations
Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
1981 • 516 citations
T-cell deficiency in patients with squamous cell cancer of the head and neck
1975 • 177 citations
Lymphokine activated killer cells
1989 • 113 citations
Natural Killer Cell Activity and Head and Neck Cancer: A Clinical Assessment<xref ref-type="fn" rid="FN2">2</xref>
1986 • 108 citations
Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck
1986 • 68 citations
Immunologic evaluation and prognosis in patients with head and neck cancer
1977 • 67 citations
Interaction of U6 snRNA with a Sequence Required for Function of the Nematode SL RNA in Trans-Splicing
1992 • 59 citations
Indomethacin sensitive suppressor-cell activity in head and neck cancer patients: The role of the adherent mononuclear cell
1988 • 50 citations
Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates
1991 • 40 citations
Head and Neck Squamous Cell Carcinoma Cell Line‐Induced Suppression of in vitro Lymphocyte Proliferative Responses
1992 • 33 citations
Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer
1990 • 32 citations
Immunologic determinants of head and neck cancer response to induction chemotherapy.
1989 • 30 citations
Definite vs Adjuvant Radiotherapy: Comparative Effects on Lymphocyte Subpopulations in Patients With Head and Neck Squamous Carcinoma
1985 • 24 citations
Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors.
1987 • 22 citations
Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
1992 • 17 citations
Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck
1989 • 15 citations
Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha
1991 • 15 citations